Loading…
avatar for Clayton Dehn

Clayton Dehn

Clinical Trials of Texas, Inc.
Senior Vice President, Early Phase Service and Strategic Development
Clayton Dehn is a research physiologist with expertise in metabolic disorders. He is the co-inventor of a process and substance for disturbing the inheritance pattern of ion-channelopathic disorders, and the sole author of the first publication cautioning against the risk of SGLT-inhibition inducing ketoacidosis in insulinopenic populations. He serves on the editorial board of three peer-reviewed journals, and has served by gubernatorial appointment on the Arizona Biomedical Research Commission.

My Speakers Sessions

Thursday, June 22
 

10:45am